The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Large Increase in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 21,300 shares, a growth of 180.3% from the September 30th total of 7,600 shares. Based on an average daily trading volume, of 26,400 shares, the days-to-cover ratio is presently 0.8 days. Based on an average daily trading volume, of 26,400 shares, the days-to-cover ratio is presently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 2.9%

CGABL stock opened at $17.70 on Friday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12-month low of $16.42 and a 12-month high of $19.87. The business’s fifty day moving average price is $18.28 and its 200 day moving average price is $17.60.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, August 1st were issued a $0.2891 dividend. This represents a $1.16 annualized dividend and a dividend yield of 6.5%. The ex-dividend date was Friday, August 1st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.